https://orcid.org/0000-0002-4058-2215
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tan-Duc Nguyen, Tomoaki Itayama, Norio Iwami, Kazuya Shimizu, Thanh-Son Dao, Thanh Luu Pham & Hideaki Maseda. (2023) Thoracic limb activity of Simocephalus vetulus and its descendants is shaped by the combination of delafloxacin and calcium. Human and Ecological Risk Assessment: An International Journal 29:5-6, pages 1013-1030.
Read now
Read now
Articles from other publishers (28)
Małgorzata Siewierska, Mateusz Gajda, Aleksandra Opalska, Michał Brudło, Paweł Krzyściak, Barbara Gryglewska, Anna Różańska & Jadwiga Wójkowska-Mach. (2023) Hospital antibiotic consumption—an interrupted time series analysis of the early and late phases of the COVID-19 pandemic in Poland, a retrospective study. Pharmacological Reports 75:3, pages 715-725.
Crossref
Crossref
Ashlan Jolley, William Love, Erin Frey & Cristina Lanzas. (2023)
Impacts of the
COVID
‐19 pandemic on antimicrobial use in companion animals in an academic veterinary hospital in North Carolina
. Zoonoses and Public Health.
Crossref
Crossref
Salma AlBahrani, Feras Almogbel, Wafa Alanazi, Saleh Hamdi Almutairi, Mohammed Alanazi, Sameh Maximos, Faten Azaiez, Assim Osman, Sharifah Almuthen, Arulanantham Zechariah Jebakumar & Jaffar A. Al-Tawfiq. (2022) Carbapenem use correlates with percentage of patients with COVID-19 in intensive care units. Infection 51:2, pages 331-336.
Crossref
Crossref
Zia UI Mustafa, Amer Hayat Khan, Sabariah Noor Harun, Muhammad Salman & Brian Godman. (2023) Antibiotic Overprescribing among Neonates and Children Hospitalized with COVID-19 in Pakistan and the Implications. Antibiotics 12:4, pages 646.
Crossref
Crossref
Dragana Sokolović, Dragana Drakul, Vesna Vujić‐Aleksić, Bojan Joksimović, Siniša Marić & Lana Nežić. (2023) Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience. Frontiers in Pharmacology 14.
Crossref
Crossref
Rajeev P. Nagassar, Narin Jalim, Arianne Mitchell, Ashley Harrinanan, Anisa Mohammed, Darren K. Dookeeram, Danini Marin, Lucia Giangreco, Paola Lichtenberger & Gustavo H. Marin. (2023) Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean. Antibiotics 12:3, pages 466.
Crossref
Crossref
Xinyi Yang, Xu Liu, Weibin Li, Lin Shi, Yingchao Zeng, Haohai Xia, Qixian Huang, Jia Li, Xiaojie Li, Bo Hu & Lianping Yang. (2023) Epidemiological Characteristics and Antimicrobial Resistance Changes of Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii under the COVID-19 Outbreak: An Interrupted Time Series Analysis in a Large Teaching Hospital. Antibiotics 12:3, pages 431.
Crossref
Crossref
Qin Xiang Ng, Natasha Yixuan Ong, Dawn Yi Xin Lee, Chun En Yau, Yu Liang Lim, Andrea Lay Hoon Kwa & Ban Hock Tan. (2023) Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review. Antibiotics 12:2, pages 409.
Crossref
Crossref
Iwona Pawłowska, Grzegorz Ziółkowski, Estera Jachowicz-Matczak, Michał Stasiowski, Mateusz Gajda & Jadwiga Wójkowska-Mach. (2023) Colonization and Healthcare-Associated Infection of Carbapenem-Resistant Enterobacteriaceae, Data from Polish Hospital with High Incidence of Carbapenem-Resistant Enterobacteriaceae, Does Active Target Screening Matter?. Microorganisms 11:2, pages 437.
Crossref
Crossref
Luis Fernando Valladales-Restrepo, Ana Camila Delgado-Araujo, Luisa Fernanda Echeverri-Martínez, Verónica Sánchez-Ríos & Jorge Enrique Machado-Alba. (2023) Use of Systemic Antibiotics in Patients with COVID-19 in Colombia: A Cross-Sectional Study. Antibiotics 12:2, pages 252.
Crossref
Crossref
Alessandro Perrella, Filomena Fortinguerra, Andrea Pierantozzi, Nicolina Capoluongo, Novella Carannante, Andrea Lo Vecchio, Francesca Futura Bernardi, Francesco Trotta & Agnese Cangini. (2023) Hospital Antibiotic Use during COVID-19 Pandemic in Italy. Antibiotics 12:1, pages 168.
Crossref
Crossref
Sumeyra Ayan, Kubra Aranci-Ciftci, Fatih Ciftci & Cem B. Ustundag. (2023) Nanotechnology and COVID-19: Prevention, diagnosis, vaccine, and treatment strategies. Frontiers in Materials 9.
Crossref
Crossref
Sara Tedeschi, Elena Sora, Andrea Berlingeri, Denis Savini, Elena Rosselli Del Turco, Pierluigi Viale & Fabio Tumietto. (2023) An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic. Antibiotics 12:1, pages 126.
Crossref
Crossref
Nicola D. Foxlee, Amsaline Lui, Agnes Mathias, Nicola Townell & Colleen L. Lau. (2022) Antibiotic Consumption in Vanuatu before and during the COVID-19 Pandemic, 2018 to 2021: An Interrupted Time Series Analysis. Tropical Medicine and Infectious Disease 8:1, pages 23.
Crossref
Crossref
Antonio Mestrovic, Nikola Perkovic, Ante Tonkic, Zeljko Sundov, Marko Kumric & Josko Bozic. (2022) Personalized Approach in Eradication of Helicobacter pylori Infection. Antibiotics 12:1, pages 7.
Crossref
Crossref
Ashley H Marx, David Cluck, Sarah B Green, Daniel T Anderson, Kayla R Stover, Daniel B Chastain, Elizabeth W Covington, Bruce M Jones, Evan Lantz, Ethan Rausch, Patrick J Y Tu, Jamie L Wagner, Cyle White, Christopher M Bland & P Brandon Bookstaver. (2022) A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications for Hospitalized Patients in 2021. Open Forum Infectious Diseases 9:12.
Crossref
Crossref
S. Sheikh, G. Vishwas, M. Aggarwal, S. Bhattacharya, P. Kumari, L. Parashar & G.G. Meshram. (2022) Antibiotic point prevalence survey at a tertiary healthcare hospital in India: Identifying strategies to improve the antibiotic stewardship program immediately after a COVID-19 wave. Infection Prevention in Practice 4:4, pages 100253.
Crossref
Crossref
Junya L. Singulani, Danielle L. Silva, Caroline M. Lima, Vanessa C. R. Magalhães, Ludmila M. Baltazar, Nalu T. A. Peres, Rachel B. Caligiorne, Alexandre S. Moura, Ana Raquel O. Santos, Tatiani Fereguetti, Juliana C. Martins, Lívia F. Rabelo, Ana C. Lyon, Susana Johann, Juliana P. Falcão & Daniel A. Santos. (2022) The impact of COVID-19 on antimicrobial prescription and drug resistance in fungi and bacteria. Brazilian Journal of Microbiology 53:4, pages 1925-1935.
Crossref
Crossref
Ippazio Cosimo Antonazzo, Carla Fornari, Davide Rozza, Sara Conti, Raffaella di Pasquale, Paolo Cortesi, Shaniko Kaleci, Pietro Ferrara, Alberto Zucchi, Giovanni Maifredi, Andrea Silenzi, Giancarlo Cesana, Lorenzo Giovanni Mantovani & Giampiero Mazzaglia. (2022) Azithromycin use and outcomes in patients with COVID-19: an observational real-world study. International Journal of Infectious Diseases 124, pages 27-34.
Crossref
Crossref
Mizuho Fukushige, Nhat-Hoang Ngo, Donny Lukmanto, Shinichi Fukuda & Osamu Ohneda. (2022) Effect of the COVID-19 pandemic on antibiotic consumption: A systematic review comparing 2019 and 2020 data. Frontiers in Public Health 10.
Crossref
Crossref
Mamoon A. Aldeyab, Stuart E. Bond, Barbara R. Conway, Jade Lee-Milner, Jayanta B. Sarma & William J. Lattyak. (2022) A Threshold Logistic Modelling Approach for Identifying Thresholds between Antibiotic Use and Methicillin-Resistant Staphylococcus aureus Incidence Rates in Hospitals. Antibiotics 11:9, pages 1250.
Crossref
Crossref
Chee Lan Lau, Petrick Periyasamy, Muhd Nordin Saud, Sarah Anne Robert, Lay Yen Gan, Suet Yin Chin, Kiew Bing Pau, Shue Hong Kong, Farah Waheeda Tajurudin, Mei Kuen Yin, Sheah Lin Ghan, Nur Jannah Azman, Xin Yun Chua, Poy Kei Lye, Stephanie Wai Yee Tan, Dexter Van Dort, Ramliza Ramli, Toh Leong Tan, Aliza Mohamad Yusof, Saw Kian Cheah, Wan Rahiza Wan Mat & Isa Naina-Mohamed. (2022) Plethora of Antibiotics Usage and Evaluation of Carbapenem Prescribing Pattern in Intensive Care Units: A Single-Center Experience of Malaysian Academic Hospital. Antibiotics 11:9, pages 1172.
Crossref
Crossref
Olivier Friedli, Michael Gasser, Alexia Cusini, Rosamaria Fulchini, Danielle Vuichard-Gysin, Roswitha Halder Tobler, Nasstasja Wassilew, Catherine Plüss-Suard & Andreas Kronenberg. (2022) Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland. Antibiotics 11:6, pages 792.
Crossref
Crossref
Gökhan Metan, Ömrüm Uzun, Gülçin Telli Dizman, Meliha Çağla Sönmezer, Ahmet Çağkan İnkaya, Gülşen Hazırolan, Murat Akova & Serhat Ünal. (2022) Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?. Infection Control & Hospital Epidemiology 43:6, pages 802-804.
Crossref
Crossref
Feras Jirjees, Munazza Ahmed, Somayeh Sayyar, Monireh Amini, Hala Al-Obaidi & Mamoon A. Aldeyab. (2022) Self-Medication with Antibiotics during COVID-19 in the Eastern Mediterranean Region Countries: A Review. Antibiotics 11:6, pages 733.
Crossref
Crossref
Larry Velásquez-Garcia, Ana Mejia-Sanjuanelo, Diego Viasus & Jordi Carratalà. (2022) Causative Agents of Ventilator-Associated Pneumonia and Resistance to Antibiotics in COVID-19 Patients: A Systematic Review. Biomedicines 10:6, pages 1226.
Crossref
Crossref
Daria Strelkova, Svetlana Rachina, Alexey Klimenko, Svetlana Yatsyshina, Dmitry Cheboksarov, Tatiana Cherkasova, Natig Ramazanov & Nataliia Ananicheva. (2022) Co-Infection in COVID-19 Pneumonia: Discussion Continues. Infection & Chemotherapy 54:4, pages 792.
Crossref
Crossref
Daria А. StrelkovaSvetlana A. RachinaV.G. KuleshovE.N. BurmistrovaIgor N. SychevN.A. AnanichevaYu.Yu. VasilevaE.A. Churkina. (2022) Microbiological monitoring of COVID-19 patients in the ICU: a prospective observational study. Clinical Microbiology and Antimicrobial Chemotherapy 24:3, pages 274-282.
Crossref
Crossref